Aneuploidy

One-sentence definition. Aneuploidy is the condition of having an incorrect number of chromosomes in a cell, typically caused by chromosomes failing to separate properly during meiosis (non-disjunction).

One-sentence analogy. Aneuploidy is what happens when you’re packing matched pairs of socks into two bags and one sock ends up in the wrong bag — the result is imbalanced and usually causes problems.

Why it matters. Y-chromosome aneuploidy is the central selective pressure in the fragile Y hypothesis. Turner syndrome (XO), which arises when the Y is lost during meiosis, occurs in approximately 3% of human conceptions and causes ~99% prenatal mortality — making aneuploidy one of the most severe genetic consequences of Y meiotic mis-segregation. The size of the pseudoautosomal region (PAR) negatively correlates with aneuploidy rate because PAR recombination ensures proper X–Y pairing during meiosis; as the PAR shrinks, segregation errors become more likely.

Where you meet it in the wiki.

• Fragile Y hypothesis — aneuploidy rate is the key variable linking PAR loss to Y chromosome loss.
• Sex chromosome evolution — aneuploidy cost governs whether SA inversions can fix.

Primary citation.

“TS occurs in ~3% of all conceptions, a high frequency for a mutation that acts effectively as a dominant lethal (TS causes 99% prenatal mortality).” — Blackmon & Demuth 2015, Finding 3

Prerequisites: none Next, learn about: pseudoautosomal region, achiasmy

Background

Aneuploidy has been central to genetics since the early twentieth century. Theodor Boveri showed in 1914 that sea urchin embryos with abnormal chromosome numbers develop abnormally, pointing to a causal role for chromosome balance. Human medicine gave aneuploidy its most studied case: in 1959, Jerome Lejeune and colleagues showed that Down syndrome results from trisomy 21, an extra copy of chromosome 21. That finding reframed aneuploidy from a curiosity into a major source of developmental disease. Work through the 1960s and 1970s established the mechanism of nondisjunction, the failure of homologs or sister chromatids to separate during meiosis. We now recognize two broad arenas where aneuploidy matters. In the germline, aneuploid gametes produce aneuploid offspring, most of which do not survive. In somatic tissue, mitotic missegregation produces aneuploid cell lineages; nearly all human solid tumors carry somatic aneuploidy. Aneuploidy also plays a constructive role in evolution: sex chromosome differentiation often passes through stages where one sex carries an odd chromosome number, and the aneuploidy cost of segregation shapes how fast that differentiation can proceed.

How it works

Aneuploidy originates when chromosomes fail to segregate correctly during cell division. In meiosis, homologs pair and separate at meiosis I; sister chromatids separate at meiosis II. Nondisjunction at either division sends both copies of a chromosome to the same cell, leaving the complementary cell with none. The resulting gametes carry n+1 or n-1 chromosomes, producing trisomy or monosomy after fertilization. Cohesin proteins hold sister chromatids together until anaphase; cohesin deteriorates over time, which is why human oocytes arrested in meiosis for decades become prone to missegregation as maternal age increases. Not all chromosomes are equally susceptible. Sex chromosomes in species with small or absent pseudoautosomal regions (PARs) are particularly at risk because the PAR provides the recombination event that holds X and Y together until anaphase I. The gene-dosage consequences of aneuploidy are severe: a cell with three copies of a chromosome expresses roughly 150 percent of the normal level of its genes, and that imbalance disrupts developmental programs and protein complexes.

A worked example

Trisomy rates in human oocytes climb steeply with maternal age. At age 20, roughly 2-5 percent of oocytes are aneuploid; by age 40, that figure exceeds 50 percent. Most trisomies are lethal in utero; trisomy 21 survives to birth at higher rates than other autosomes because chromosome 21 is small and its extra gene content causes less dosage disruption. Turner syndrome (45,X) offers a second worked example relevant to this lab. Turner syndrome arises when the Y is lost or an X fails to segregate. We find in Blackmon and Demuth (2015) that Turner syndrome occurs in roughly 3 percent of all human conceptions, nearly all of which end in prenatal loss. This high frequency illustrates the selective pressure at the heart of the fragile Y hypothesis: as the PAR shrinks and X-Y recombination is lost, Y aneuploidy becomes more likely, and the cost of carrying a Y rises. In insect natural populations, species with very small PARs or achiasmatic males show elevated rates of sex-chromosome aneuploidy in cytological surveys.

Common misconceptions

• Aneuploidy is not polyploidy. Polyploidy adds one or more complete chromosome sets; aneuploidy adds or removes individual chromosomes. The two differ in gene dosage balance, fitness consequences, and evolutionary potential. Read about polyploidy for the distinction.
• Most aneuploidy is lethal, not merely harmful. The majority of aneuploid human conceptions are lost before clinical detection. Viable trisomies (21, 18, 13, X, Y) are the exceptions, not the rule.
• Mosaic aneuploidy is common and does not always cause disease. When missegregation occurs during mitosis after the first few cleavages, only some cells carry the abnormal number. Mosaic Turner and mosaic Down syndrome individuals often have milder phenotypes than full trisomy cases.
• Aneuploidy and chromosome number evolution are distinct phenomena. Evolutionary changes in chromosome number (as we study with chromePlus and related models) happen when structural rearrangements fix in a population. Aneuploidy is an error within individuals, not a population-level change.
• Sex-chromosome aneuploidy is not the same as sex-chromosome evolution. XO individuals (Turner syndrome) are aneuploid; XO species (some grasshoppers) have fixed a monosomy over evolutionary time. Context determines whether a given karyotype is an error or a stable derived state.

How to spot it in papers

• Look for the terms nondisjunction, missegregation, and segregation error. These signal mechanistic discussion of aneuploidy even when the word itself does not appear.
• Check whether the paper distinguishes germline from somatic aneuploidy. Cancer studies focus on somatic; evolutionary and developmental studies typically focus on germline.
• Watch for maternal age as a covariate in human studies. Its presence usually signals that meiotic cohesin decay is under discussion.
• Papers that report aneuploidy rates by cytological methods often conflate structural rearrangements with whole-chromosome gains or losses. Confirm that the paper distinguishes these; they require different models.
• In sex chromosome evolution studies, aneuploidy rate is often derived from PAR length or recombination rate rather than measured directly. Note whether the paper uses cytological counts or model estimates, since the two can diverge.

Further reading

Within the wiki, we suggest polyploidy for the contrast between whole-set and single-chromosome copy-number change, msci for sex-chromosome-specific transcriptional silencing and its relation to segregation, and sa-fusion for how sexually antagonistic selection on fusions interacts with aneuploidy cost.